Vamorolone is Currently Under Review with the FDA for the Treatment of Duchenne Muscular Dystrophy, a Rare Neuromuscular Disease FDA has Granted Fast Track and Orphan Drug Designation for Vamorolone. | June 20, 2023
, 1, 2023 - Surge Battery Metals Inc. is pleased to announce a non-brokered private placement of up to 17,900,000 units at a price of $0.40 per Unit. Each Unit will consist of one common share and one share purchase warrant . Each share purchase. - Veroeffentlicht am 01.06.2023
VANCOUVER, BC / ACCESSWIRE / May 30, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Hank Payments and FPX Nickel Corp discussing their latest news.The Power
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.